Federal Register / Vol. 74, No. 69 / Monday, April 13, 2009 / Notices 16871 

President) 701 East Byrd Street, 

Richmond, Virginia 23261–4528: 

1. MidCap Financial Holdings, LLC, 

and MidCap Bank Holdings, Inc., both 

of Bethesda, Maryland, to become bank 

holding companies by acquiring 100 

percent of the voting shares of ISN 

Bank, Cherry Hill, New Jersey. 

In connection with this application, 

MidCap Financial Holdings, LLC, 

Bethesda, Maryland, also has applied to 

engage in extending credit and servicing 

loans through MidCap Financial 

Intermediate Holdings, LLC; MidCap 

Financial, LLC; and MidCap Funding I, 

LLC, all of Bethesda, Maryland, 

pursuant to section 225.28(b)(1) of 

Regulation Y. 

Board of Governors of the Federal Reserve 

System, April 8, 2009. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E9–8327 Filed 4–10–09; 8:45 am] 

BILLING CODE 6210–01–S 

GENERAL SERVICES 

ADMINISTRATION 

Multiple Award Schedule Advisory 

Panel; Notification of Public Advisory 

Panel Meetings 

AGENCY: U.S. General Services 

Administration (GSA). 

ACTION: Notice. 

SUMMARY: The U.S. General Services 

Administration (GSA) Multiple Award 

Schedule Advisory Panel (MAS Panel), 

a Federal Advisory Committee, will 

hold a public meeting on Friday, May 1, 

2009. GSA utilizes the MAS program to 

establish long-term Governmentwide 

contracts with responsible firms to 

provide Federal, State, and local 

government customers with access to a 

wide variety of commercial supplies 

(products) and services. 

The MAS Panel was established to 

develop advice and recommendations 

on MAS program pricing policies, 

provisions, and procedures in the 

context of current commercial pricing 

practices. The Panel is developing 

recommendations for MAS program 

pricing provisions for the acquisition of 

(1) professional services; (2) products; 

(3) total solutions which consist of 

professional services and products; and 

(4) non professional services. In 

developing the recommendations, the 

Panel will, at a minimum, address these 

5 questions for each of the 4 types of 

acquisitions envisioned above: (1) 

Where does competition take place?; (2) 

If competition takes place primarily at 

the task/delivery order level, does a fair 

and reasonable price determination at 

the MAS contract level really matter?; 

(3) If the Panel consensus is that 

competition is at the task order level, 

are the methods that GSA uses to 

determine fair and reasonable prices 

and maintain the price/discount 

relationship with the basis of award 

customer(s) adequate?; (4) If the current 

policy is not adequate, what are the 

recommendations to improve the 

policy/guidance; and (5) If fair and 

reasonable price determination at the 

MAS contract level is not beneficial and 

the fair and reasonable price 

determination is to be determined only 

at the task/delivery order level, then 

what is the GSA role? 

The meeting will be held at U.S. 

General Services Administration, 

Federal Acquisition Service, 2200 

Crystal Drive, Room L1301, Arlington, 

VA 22202. The location is within 

walking distance of the Crystal City 

metro stop. The start time for each 

meeting is 9 a.m., and each meeting will 

adjourn no later than 5 p.m. 

FOR FURTHER INFORMATION CONTACT: 

Information on the Panel meetings, 

agendas, and other information can be 

obtained at www.gsa.gov/ 

masadvisorypanel or you may contact 

Ms. Pat Brooks, Designated Federal 

Officer, Multiple Award Schedule 

Advisory Panel, U.S. General Services 

Administration, 2011 Crystal Drive, 

Suite 911, Arlington, VA 22205; 

telephone (703) 605–3406, Fax (703) 

605–3454; or via email at 

mas.advisorypanel@gsa.gov. 

AVAILABILITY OF MATERIALS: All 

meeting materials, including meeting 

agendas, handouts, public comments, 

and meeting minutes will be posted on 

the MAS Panel website at www.gsa.gov/ 

masadvisorypanel or www.gsa.gov/ 

masap. 

MEETING ACCESS: Individuals 

requiring special accommodations at 

any of these meetings should contact 

Ms. Brooks at least ten (10) business 

days prior to the meeting date so that 

appropriate arrangements can be made. 

Dated: April 7, 2009. 

Rodney P. Lantier, 

Acting Deputy Chief Acquisition Officer and 

Senior Procurement Executive, Office of the 

Chief Acquisition Officer, General Services 

Administration. 

[FR Doc. E9–8320 Filed 4–10–09; 8:45 am] 

BILLING CODE 6820–EP–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood Safety and Availability 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services is hereby giving notice that the 

Advisory Committee on Blood Safety 

and Availability (ACBSA) will hold a 

meeting. The meeting will be open to 

the public. 

DATES: The meeting will take place 

Thursday, April 30 and Friday, May 1, 

2009 from 9 a.m. to 5 p.m. 

ADDRESSES: The Universities at Shady 

Grove, 9630 Gudelsky Drive, Rockville, 

MD 20850, Phone: 301–738–6000. 

FOR FURTHER INFORMATION CONTACT: Jerry 

A. Holmberg, PhD, Executive Secretary, 

Advisory Committee on Blood Safety 

and Availability, Office of Public Health 

and Science, Department of Health and 

Human Services, 1101 Wootton 

Parkway, Suite 250, Rockville, MD 

20852, (240) 453–8803, FAX (240) 453– 

8456, e-mail ACBSA@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Advisory Committee on Blood Safety 

and Availability provides advice to the 

Secretary and the Assistant Secretary for 

Health on a range of policy issues that 

impact (1) definition of public health 

parameters around safety and 

availability of the blood supply and 

blood products, (2) broad public health, 

ethical and legal issues related to 

transfusion and transplantation safety, 

and (3) the implications for safety and 

the availability of various economic 

factors affecting product cost and 

supply. In keeping with its established 

mission, the ACBSA has been asked to 

explore processes and parameters which 

should be used in the decision-making 

process for transfusion and 

transplantation safety policy. At the 

April 30 to May 1, 2009 meeting, the 

Committee will be asked to comment on 

evidenced-based, zero-risk, cost, benefit 

and comparative effectiveness, societal 

position or mandate, ethical, and 

stakeholders concerns. 

The public will have opportunity to 

present their views to the Committee on 

both meeting days. A public comment 

session has been scheduled for April 30 

and May 1, 2009. Comments will be 

limited to five minutes per speaker and 

must be pertinent to the discussion. Preregistration is required for participation 

in the public comment session. Any